sar425899 glucagon glp-1 dual agonist sanofi Receptor occupancy of glucagon-like peptide 1/glucagon receptor in individuals with type 2 diabetes Retatrutide, a GIP, GLP-1 and
Description
Do not reuse
01053-X/asset/826330f0-5581-4d6d-8f45-2192fe6ac242/main.assets/gr2_lrg.jpg)
Learn how GLP-1 works, plus GLP-1 promoting foods that may naturally support this powerful weight loss hormone, with or without medication.

Although rare, associations with nonarteritic anterior ischemic optic neuropathy, pancreatitis, medullary thyroid carcinoma, and acute kidney injury (AKI) have been reported, primarily through pharmacovigilance and case-based evidence

Certainly, the apparent advantage of tirzepatide, a dual incretin agonist, over GLP-1RA will spark renewed interest in the therapeutic potential of GIP in type 2 diabetes, obesity and related co-morbidities.

### Funding Statement SDL and AC were supported by the National Science Foundation (Grant Nos.\ CAREER DMS-1944574 and DMS-2325258) ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained

This natural GLP-1 support supplement is ideal for individuals seeking
